mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.08 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |